共 111 条
[1]
Ip MS(2009)A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with observation to treat vision loss associated with macular edema secondary to central retinal vein occlusion: the Standard Care Arch Ophthalmol 127 1101-2460
[2]
Scott IU(2011) Corticosteroid for Retinal Vein Occlusion (SCORE) Study Report 5 Ophthalmology 118 2453-1133.e1
[3]
VanVeldhuisen PC(2010)Dexamethasone intravitreal implant in patients with macular edema related to branch or central retinal vein occlusion twelve-month study results Ophthalmology 117 1124-456
[4]
Oden NL(2009)Ranibizumab for macular edema following central retinal vein occlusion: six-month primary end point results of a phase III study Br J Ophthalmol 93 452-621
[5]
Blodi BA(2011)Intravitreal bevacizumab (Avastin) for macular oedema secondary to retinal vein occlusion: 12-month results of a prospective clinical trial J Ocul Pharmacol Ther 27 615-2049
[6]
Fisher M(2011)Intravitreal bevacizumab for treatment of macular edema secondary to central retinal vein occlusion: eighteen-month results of a prospective trial Ophthalmology 118 2041-1063
[7]
Haller JA(2013)Sustained benefits from ranibizumab for macular edema following central retinal vein occlusion: twelve-month outcomes of a phase III study Ophthalmology 120 1057-185
[8]
Bandello F(2012)Predictive value in retinal vein occlusions of early Angiogenesis 15 171-208
[9]
Belfort R(2014) late or incomplete ranibizumab response defined by optical coherence tomography Ophthalmology 121 202-1420.e1
[10]
Blumenkranz MS(2014)Binding and neutralization of vascular endothelial growth factor (VEGF) and related ligands by VEGF Trap, ranibizumab and bevacizumab Ophthalmology 121 1414-2443